2021新闻发布

日期

标题

28/5/2021

Beroni Group Issues US$2 Million of Convertible Notes to Fund Research and Development Plans

28/5/2021

Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment

27/4/2021

Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

3/2/2021

Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company